 Ticlopidine
"Ticlopidine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Ticlopidine is an effective inhibitor of platelet aggregation. The drug has been found to significantly reduce infarction size in acute myocardial infarcts and is an effective antithrombotic agent in arteriovenous fistulas, aorto-coronary bypass grafts, ischemic heart disease, venous thrombosis, and arteriosclerosis.
| Descriptor ID |
D013988
|
| MeSH Number(s) |
D02.886.778.823.500 D03.383.725.849.500 D03.383.903.830.500 D03.438.928.500
|
| Concept/Terms |
Ticlodix- Ticlodix
- Vitoria Brand of Ticlopidine Hydrochloride
Ticlodone- Ticlodone
- Almirall Brand of Ticlopidine Hydrochloride
Ticlid- Ticlid
- Roche Brand of Ticlopidine Hydrochloride
|
Below are MeSH descriptors whose meaning is more general than "Ticlopidine".
Below are MeSH descriptors whose meaning is more specific than "Ticlopidine".
This graph shows the total number of publications written about "Ticlopidine" by people in this website by year, and whether "Ticlopidine" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 | | 2000 | 1 | 0 | 1 | | 2001 | 0 | 1 | 1 | | 2002 | 0 | 1 | 1 | | 2003 | 1 | 1 | 2 | | 2004 | 1 | 0 | 1 | | 2005 | 3 | 0 | 3 | | 2006 | 3 | 1 | 4 | | 2007 | 1 | 2 | 3 | | 2008 | 3 | 4 | 7 | | 2009 | 5 | 3 | 8 | | 2010 | 4 | 2 | 6 | | 2011 | 7 | 2 | 9 | | 2012 | 3 | 0 | 3 | | 2013 | 5 | 1 | 6 | | 2014 | 1 | 1 | 2 | | 2015 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Ticlopidine" by people in Profiles.
-
Gremmel T, Frelinger AL, Michelson AD. Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization. PLoS One. 2015; 10(8):e0134599.
-
Spencer FA, Guyatt G. ACP journal club. Dual antiplatelets for 30 mo after drug-eluting stents reduced stent thrombosis and CV and cerebrovascular events. Ann Intern Med. 2015 Mar 17; 162(6):JC9.
-
Keaney JF. Balancing the risks and benefits of dual platelet inhibition. N Engl J Med. 2015 May 7; 372(19):1854-6.
-
Hochholzer W, Ruff CT, Mesa RA, Mattimore JF, Cyr JF, Lei L, Frelinger AL, Michelson AD, Berg DD, Angiolillo DJ, O'Donoghue ML, Sabatine MS, Mega JL. Variability of individual platelet reactivity over time in patients treated with clopidogrel: insights from the ELEVATE-TIMI 56 trial. J Am Coll Cardiol. 2014 Jul 29; 64(4):361-8.
-
Silver B, Wulf Silver R. Stroke: transient ischemic attack. FP Essent. 2014 May; 420:11-5.
-
Mansoor AH, Mujtaba MT, Silver B. Antiplatelet therapy to prevent recurrent stroke: Three good options. Cleve Clin J Med. 2013 Dec; 80(12):787-95.
-
Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A, Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL, Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014 Jan 25; 383(9914):333-41.
-
Kakouros N, Kickler TS, Laws KM, Rade JJ. Hematocrit alters VerifyNow P2Y12 assay results independently of intrinsic platelet reactivity and clopidogrel responsiveness. J Thromb Haemost. 2013 Oct; 11(10):1814-22.
-
Malloy RJ, Kanaan AO, Silva MA, Donovan JL. Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis. Clin Ther. 2013 Oct; 35(10):1490-1500.e7.
-
Sorkin GC, Dumont TM, Wach MM, Eller JL, Mokin M, Natarajan SK, Baxter MS, Snyder KV, Levy EI, Hopkins LN, Siddiqui AH. Carotid artery stenting outcomes: do they correlate with antiplatelet response assays? J Neurointerv Surg. 2014 Jun; 6(5):373-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|